Search

Daniel Baram, MD
His practice includes Endobronchial Ultrasound (EBUS), Bronchial Stenting, Electrocautery and Argon Plasma Coagulation, Balloon Dilation and Stenting, Bronchial Thermoplasty for treatment of severe persistent asthma, electro navigational bronchoscopy and other aspects of diagnostic and therapeutic…
Dalia Haydar, Pharm.D., Ph.D.
Dr. Haydar's aim is to investigate mechanisms responsible for the lack of CAR T cell efficacy in pediatric brain tumors using cutting-edge technologies and innovative animal models that recapitulate human disease and barriers for adoptive immunotherapies.
Fayez Estephan, MD
His special interests include gastrointestinal and genitourinary malignancies.
Jennifer Levine, MD
Cancer Survivorship
Joao Ascensao, MD, PhD, FACP
Dr Ascensão has been working with many of his Hematology-Oncology fellows in projects that look at various aspects of the clinical behavior of hematological malignancies, particularly in African-American patients.
Jennifer Vaz, MD
Dr. Vaz treats patients with a range of gynecologic cancers, including uterine, ovarian, cervical, vulvar, and vaginal, as well as gestational trophoblastic disease. She has interests in both clinical trials with immunotherapy and medical education.
Lekhaj Daggubati, MD, MS
Dr. Daggubati strives for improved patient outcomes by incorporating enhanced recovery protocols and leveraging the latest in perioperative and intraoperative technology. Dr. Duggabati also has expertise in Data Science with a Masters in Data Sciences from Northwestern University with a…
Rohit Jain, MD
Diabetes, Obesity, Thyroid, Adrenal Disorders, Metabolic Bone Disease, Health Services
Matthew Ng, MD
He specializes in minimally invasive surgical techniques along with robotic surgery for malignant and benign diseases including inflammatory bowel disease. He also practices transanal minimally invasive surgery for rectal pathologies. Dr. Ng has a deep interest for anal disorders as well, including…
Eric Yvon, PhD
Dr. Yvon leads the Stem Cell transplantation and the CAR gene-modified T-cell and NK-cell programs that are developing innovative strategies to enhance T and NK cells survival, proliferation, and tumor targeting within the immunosuppressive tumor micro-environment.